PHIP

	Lepu Biopharma Co., Ltd. - B
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

► WARNING ► IMPORTANT ► EXPECTED TIMETABLE ► CONTENTS ► SUMMARY ► DEFINITIONS ► GLOSSARY OF TECHNICAL TERMS ► FORWARD-LOOKING STATEMENTS ► RISK FACTORS ► WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM STRICT COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE ► INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED] ► DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED] ► CORPORATE INFORMATION ► INDUSTRY OVERVIEW ► REGULATORY OVERVIEW ► HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE ► BUSINESS ► CONNECTED TRANSACTIONS ► DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT ► RELATIONSHIP WITH CONTROLLING SHAREHOLDER ► SUBSTANTIAL SHAREHOLDERS ► SHARE CAPITAL ► FINANCIAL INFORMATION ► FUTURE PLANS AND USE OF PROCEEDS ► CORNERSTONE INVESTORS ► [REDACTED] ► STRUCTURE OF THE [REDACTED] ► HOW TO APPLY FOR [REDACTED] ► APPENDIX I - ACCOUNTANT'S REPORT ► APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION ► APPENDIX III - LOSS ESTIMATE ► APPENDIX IV - PROPERTY VALUATION REPORT ► APPENDIX V - TAXATION AND FOREIGN EXCHANGE ► APPENDIX VI - SUMMARY OF PRINCIPAL LEGAL AND REGULATORY PROVISIONS ► APPENDIX VII - SUMMARY OF THE ARTICLES OF ASSOCIATION ► APPENDIX VIII - STATUTORY AND GENERAL INFORMATION ► APPENDIX IX - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE FOR INSPECTION